LENSAR Inc Q3 2024 Everything You Need To Know Ahead Of Earnings
| 45866FAH7 | 86.22 0.72 0.84% |
About 52% of 45866FAH7's investor base is interested to short. The analysis of the overall prospects from investing in INTERCONTINENTAL EXCHANGE INC suggests that many traders are, at the present time, impartial. The current market sentiment, together with 45866FAH7's historical and current headlines, can help investors time the market. In addition, many technical investors use INTERCONTINENTAL EXC bond news signals to limit their universe of possible portfolio assets.
45866FAH7 |
LENSAR Inc is set to release its Q3 2024 earnings on Nov 7, 2024. The consensus estimate for Q3 2024 revenue is 11.50 million, and the earnings are expe
Read at gurufocus.com
 |
INTERCONTINENTAL EXC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 45866FAH7 bond to make a market-neutral strategy. Peer analysis of 45866FAH7 could also be used in its relative valuation, which is a method of valuing 45866FAH7 by comparing valuation metrics with similar companies.
Peers
45866FAH7 Related Equities
| CBTN | Citizens Bancorp | 2.04 | ||||
| PFLT | PennantPark Floating | 0.81 | ||||
| FRHC | Freedom Holding | 0.38 | ||||
| EQIX | Equinix | 0.24 | ||||
| SEIC | SEI Investments | 0.23 | ||||
| BK | Bank of New York | 0.16 | ||||
| SBRA | Sabra Healthcare | 0.95 |
Other Information on Investing in 45866FAH7 Bond
45866FAH7 financial ratios help investors to determine whether 45866FAH7 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 45866FAH7 with respect to the benefits of owning 45866FAH7 security.